| Literature DB >> 25806060 |
Hailong Yu1, Liangbi Xiang1, Wenjing Xu2, Bin Zhao2, Yu Wang2, Jiang Peng2, Shibi Lu2.
Abstract
Sciatic nerves from allogeneic Sprague-Dawley rats were pretreated with chondroitinase ABC and were used to bridge damaged sciatic nerves in Wistar rats. Chondroitin sulfate proteoglycans were removed from the chemically extracted acellular nerves. At 3 months after grafting, the footplate pinch test result was positive in the Wistar rats. Autotomy scores decreased, and increased muscular contraction tension appeared when triceps surae muscles were stimulated. In addition, the recovery rate of wet triceps surae muscle weight increased, and the distal segment of the chondroitinase ABC-treated graft exhibited Schwann cells next to the nerve fibers. These results suggested that chondroitinase ABC pretreatment enhanced repair of long nerve defects via acellular nerve grafting.Entities:
Keywords: Schwann cell; chondroitinase ABC; neural regeneration; peripheral nerve; sciatic nerve
Year: 2012 PMID: 25806060 PMCID: PMC4354120 DOI: 10.3969/j.issn.1673-5374.2012.01.010
Source DB: PubMed Journal: Neural Regen Res ISSN: 1673-5374 Impact factor: 5.135
Figure 125-mm long acellular nerve graft used to bridge the gap in the sciatic nerve.
Figure 2Histological observations of rats following sciatic nerve injury bridging.
Neurofilament-200 (green)/S-100 (red) double immunofluorescent cross-section of the proximal nerve segment from the chondroitinase ABC (ChABC) treatment group (A), distal segment of the ChABC treatment group (B), proximal nerve segment of the control group (C), and distal segment of the control group (D). Scale bars: 200 μm.